SYS6010 Versus Docetaxel for Previously Treated EGFR Wild-type NSCLC: Phase Ⅲ
Clinical trial NCT07442565 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07442565
- Sponsor
- CSPC Megalith Biopharmaceutical Co.,Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-10
- Primary completion
- 2027-12-30
- Enrollment
- 506
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.